Novo Nordisk A/S - share repurchase programme

Under the programme initiated 9 May 2023, Novo Nordisk will repurchase B shares for an amount up to DKK 5.8 billion in the period from 10 May 2023 to 8 Aug...

June 20, 2023 | Tuesday | News
QIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes

QIAGEN N.V.  announced  a notice (reiterating its notice to holders dated January 9, 2019) to holders of the following: - 0.500% Senior Unsecure...

June 19, 2023 | Monday | News
Bristol Myers Squibb Announces Dividend

Bristol Myers Squibb (NYSE: BMY)  announced that its Board of Directors has declared a quarterly dividend of fifty-seven cents ($0.57) per share on th...

June 15, 2023 | Thursday | News
Philips to repurchase up to 7.1 million shares to cover long-term incentive plans

The repurchases will be executed through one or more individual forward transactions, expected to be entered into in the second and/or the third quarter of...

June 15, 2023 | Thursday | News
Labcorp Announces Information in Connection with its Spin-off of Fortrea

The record date will be 5 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and The distribution date will be 11:59 p.m. Burlington, North...

June 12, 2023 | Monday | News
Seagen Stockholders Approve Acquisition by Pfizer

Following a special meeting of its stockholders, Seagen Inc. (Nasdaq: SGEN) today announced that its stockholders voted to approve a proposal to adopt the ...

May 31, 2023 | Wednesday | News
Illumina shareholders re-elect eight of nine Illumina directors

Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 ...

May 26, 2023 | Friday | News
Merck Announces Third-Quarter 2023 Dividend

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and imp...

May 24, 2023 | Wednesday | News
Catalent Holds Business Update Call Amid Third Quarter Results Delay and NYSE Notice

the Company’s ongoing focus on finalizing its financial statements and other disclosures in its Quarterly Report on Form 10-Q for the fiscal quarter ...

May 22, 2023 | Monday | News
Agilent Announces Cash Dividend of 22.5 Cents Per Share

Agilent Technologies Inc. (NYSE: A)  announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on July 26, 2023, ...

May 18, 2023 | Thursday | News
Pfizer Prices $31,000,000,000 Debt Offering

$3,000,000,000 aggregate principal amount of 4.650% Notes due 2025 $3,000,000,000 aggregate principal amount of 4.450% Notes due 2026 $4,000,000,000 aggr...

May 17, 2023 | Wednesday | News
Catalent Advises Stockholders to Reject TRC Capital's Mini-Tender Offer

Catalent does not endorse TRC’s unsolicited mini-tender offer and recommends that stockholders do not tender their shares in response to this unsolic...

May 08, 2023 | Monday | News
Rakovina Therapeutics Inc. Announces 2022 Financial Results and Convertible Debenture Financing

Rakovina Therapeutics also announced that it will issue approximately thirty (30) unsecured $50,000 convertible debenture units to a select group of i...

May 02, 2023 | Tuesday | Company results
Merck Approves all Agenda Items at Annual General Meeting

Merck, a leading science and technology company, held its 28th Annual General Meeting virtually today. All of the resolutions on the agenda were approved, ...

April 30, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close